Medical Devices Startups

Emerging Therapy Solutions provides comprehensive management solutions for cell and gene therapies and transplants to payers, self-insured employers, and secondary payers. The company offers patient identification, care navigation, outcomes monitoring, and risk pooling services to help organizations anticipate and manage the costs and complexities of these therapies.

1 investor

Emerus operates neighborhood hospitals across the United States that provide emergency, inpatient, and ambulatory care services to underserved communities. The company partners with leading health systems to deliver patient-centered acute and primary care in community settings.

1 investor

EMHANCE is an early-stage medical device startup developing a portable, non-invasive neurostimulation system that delivers low-frequency pulsed electromagnetic fields to the brain, using integrated sensors and an AI-driven feedback loop to adapt stimulation to the individual. It targets patients with neurological conditions and their clinicians, with session data shared for remote clinical oversight.

1 investor

EMILY.AI develops an automated closed-loop oxygen therapy system that uses over 40 monitored parameters and neural network algorithms to customize long-term oxygen therapy in real-time for patients. The system is designed for respiratory care and has demonstrated 87% stable oxygen saturation levels in functional prototypes.

1 investor

Emmetros develops a collaboration tool designed for care teams to deliver person-centered care while prioritizing independence and dignity for care recipients. The platform serves healthcare and care organizations in Canada and the USA.

1 investor

Emovi Inc commercializes KneeKG, a regulatory-cleared clinical assessment tool that measures knee movement patterns to evaluate functional deficiencies and aid in orthopaedic decision-making for pain management and surgical planning.

1 investor

Emovocare is a small team that designs and engineers assistive robotics products aimed at improving the quality of life for people with motor impairments. The company works with the EPFL BioRob laboratory and focuses on inclusion-oriented human-machine interfaces and clinical engineering.

1 investor

Empallo provides telehealth cardiac care led by cardiac specialists, offering treatment plans, medication management, and at-home testing options such as Holter monitoring and sleep studies. It serves patients seeking cardiovascular care remotely from home.

1 investor

Empo Health provides remote monitoring tools for diabetic patients at risk of foot ulcers, including an imaging scale and patient monitoring service that enables providers to track foot health and detect issues earlier. The system targets diabetic patients and healthcare providers managing diabetic neuropathy complications.

1 investor

Emtora Biosciences is a clinical-stage life science company developing eRapa, a novel formulation of rapamycin, to prevent the onset and recurrence of cancer. Its lead program, Serenta (eRapa), is in a Phase 3 trial evaluating safety and efficacy in patients diagnosed with familial adenomatous polyposis (FAP).

1 investor

Emulsi develops NanoLIPID™, a natural lipid technology that self-assembles into nano-structures for encapsulating active pharmaceutical ingredients, nutraceuticals, and bioactive compounds. The platform targets oral drug delivery, cosmetics, and nutraceutical applications.

1 investor

EnAcuity develops AI-powered software for real-time surgical image enhancement using hyperspectral imaging, delivered as a software-only solution that integrates with existing operating room equipment. The company targets surgeons and surgical facilities seeking improved intraoperative visualization without additional hardware.

1 investor

EncephalX develops the Dynamic Cranioplasty System (DCPS), a cranial implant that treats traumatic brain injuries and strokes in a single procedure rather than the conventional two surgeries. The device targets neurosurgery care for patients requiring intracranial decompression, positioned in the medical device industry.

1 investor

Enclony builds high-speed vision inspection systems for pharmaceutical manufacturing, used to inspect tablets, capsules, and tablet-capsule hybrids and to verify laser marking. Its equipment serves drug manufacturers requiring high-throughput quality inspection.

1 investor

Endiatx develops swallowable robotic capsules that physicians can navigate inside the stomach to capture live video and spatial data, offering an alternative to traditional upper GI endoscopy. Its investigational devices target medical visualization, navigation, and intervention for gastrointestinal care.

1 investor

Endimension develops AI algorithms to automatically detect abnormalities and diseases from medical scans, designed to reduce misdiagnosis, lower radiologist workload, and improve patient outcomes in healthcare. The company was incubated at IIT Bombay and is staffed by machine learning researchers, software engineers, and medical doctors.

1 investor

Keenova is a specialty therapeutics company focused on rare, stigmatized, or unaddressed conditions across areas including immunology, urology, hepatology, ophthalmology, orthopedics, and critical care. Par Health develops generic pharmaceuticals, sterile injectables, and active pharmaceutical ingredients with U.S.-based manufacturing capabilities.

1 investor

Endo GI Medical develops medical devices for plastic stent delivery in biliary and pancreatic duct procedures, enabling drainage through a single cannulation while maintaining guidewire position. The company's systems have received FDA clearance and are used in interventional endoscopy procedures.

1 investor

Novartis is a pharmaceutical company developing breakthrough medicines across therapeutic areas including oncology and cardiovascular disease.

1 investor

Endodiag develops non-invasive diagnostic tests based on blood biomarkers to identify endometriosis in women, addressing a condition currently requiring surgical diagnosis. The company also creates solutions to map patient disease for personalized treatment and fertility management.

1 investor

EndoDNA + BIOS is a precision health intelligence platform for licensed healthcare practitioners that integrates genomic analysis, biomarkers, lifestyle data, and machine learning into a clinical decision-support system. The platform combines DNA sequencing with an AI reasoning engine to generate unlimited personalized wellness reports and treatment recommendations from a single patient DNA sample.

1 investor

Endolipid Therapeutics is a biotech developing SHBG-mimicking peptides aimed at reducing ectopic fat accumulation to treat conditions such as fatty liver disease and NASH, as well as cellulite. Its work spans therapeutic and dermocosmetic applications.

1 investor

Endometrics develops a non-invasive diagnostic test for endometriosis using menstrual blood samples and proprietary molecular biomarkers for women's healthcare. The company combines clinical validation with machine learning to identify endometriosis without invasive procedures.

1 investor

EndoProTech develops anti-inflammatory liposomes designed to modify the composition of cell plasma membranes and reduce microvascular dysfunction following ischemia/reperfusion injury. Its research targets reducing infarct size after myocardial infarction while preserving tissue viability and shortening recovery time.

1 investor